Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems

In a previous issue of Arthritis Research and Therapy, Ursum and colleagues report the relative stabilities of anticitrullinated protein/peptide antibodies (ACPAs) and IgM rheumatoid factors during the course of rheumatoid arthritis and their differential correlation with markers of the acute-phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Valesini, Guido, Alessandri, Cristiano
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787266/
https://www.ncbi.nlm.nih.gov/pubmed/19796372
http://dx.doi.org/10.1186/ar2786
_version_ 1782174895415754752
author Valesini, Guido
Alessandri, Cristiano
author_facet Valesini, Guido
Alessandri, Cristiano
author_sort Valesini, Guido
collection PubMed
description In a previous issue of Arthritis Research and Therapy, Ursum and colleagues report the relative stabilities of anticitrullinated protein/peptide antibodies (ACPAs) and IgM rheumatoid factors during the course of rheumatoid arthritis and their differential correlation with markers of the acute-phase response. These findings add to a growing body of evidence highlighting the distinct nature of these two autoantibody systems and the role of ACPAs as a disease-specific marker of rheumatoid arthritis.
format Text
id pubmed-2787266
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27872662009-12-02 Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems Valesini, Guido Alessandri, Cristiano Arthritis Res Ther Editorial In a previous issue of Arthritis Research and Therapy, Ursum and colleagues report the relative stabilities of anticitrullinated protein/peptide antibodies (ACPAs) and IgM rheumatoid factors during the course of rheumatoid arthritis and their differential correlation with markers of the acute-phase response. These findings add to a growing body of evidence highlighting the distinct nature of these two autoantibody systems and the role of ACPAs as a disease-specific marker of rheumatoid arthritis. BioMed Central 2009 2009-09-14 /pmc/articles/PMC2787266/ /pubmed/19796372 http://dx.doi.org/10.1186/ar2786 Text en Copyright ©2009 BioMed Central Ltd
spellingShingle Editorial
Valesini, Guido
Alessandri, Cristiano
Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems
title Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems
title_full Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems
title_fullStr Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems
title_full_unstemmed Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems
title_short Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems
title_sort anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787266/
https://www.ncbi.nlm.nih.gov/pubmed/19796372
http://dx.doi.org/10.1186/ar2786
work_keys_str_mv AT valesiniguido anticitrullinatedproteinpeptideantibodiesandrheumatoidfactorstwodistinctautoantibodysystems
AT alessandricristiano anticitrullinatedproteinpeptideantibodiesandrheumatoidfactorstwodistinctautoantibodysystems

Ejemplares similares